已收盘 02-06 16:00:00 美东时间
+0.590
+3.60%
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
Evercore ISI Group analyst Vijay Kumar downgrades Bausch & Lomb (NYSE:BLCO) from Outperform to In-Line and maintains the price target from $18 to $18.
01-06 01:57
医疗健康消费正经历“悦己”与“专业”的双重升级。眼部护理领域,品牌通过情感化IP与硅水凝胶科技,实现“颜值”与“健康”的平衡;健康器械赛道,则以轻量化场景和智能...
01-05 15:51
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley analyst Patrick Wood upgrades Bausch & Lomb (NYSE:BLCO) from Equal-Weight to Overweight and raises the price target from $14 to $21.
2025-12-03 01:25
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program, created in collaboration
2025-11-10 20:15
(来源:经济日报) 转自:经济日报 随着京东健康11.11进入高潮阶段,海量健康产品迎来年度低价,多重玩法同步上线,为用户带来实实在在的优惠。11月9日晚8点至...
2025-11-10 09:47
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
2025-11-03 20:20
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
2025-10-31 10:25